🇺🇸 FDA
Pipeline program

Lucinactant

KL4-MAS-03

Phase 3 small_molecule terminated

Quick answer

Lucinactant for Meconium Aspiration is a Phase 3 program (small_molecule) at WINDTREE THERAPEUTICS INC /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
WINDTREE THERAPEUTICS INC /DE/
Indication
Meconium Aspiration
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials